ArticleHuman vaccines & immunotherapeutics2022

Omicron, a new SARS-CoV-2 variant: assessing the impact on severity and vaccines efficacy.

Gaurav Joshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.